Menopause

The North American Menopause Society released its 2023 Nonhormone Therapy Position Statement recommending up-to-date scientific evidence for nonhormonal options for managing menopausal symptoms.

Continuous use of transdermal nitroglycerin did not result in sustained improvements in hot flash frequency or severity compared with placebo among peri- and postmenopausal women, according to results of a randomized clinical trial.

Kristin E. Rojas, MD, FACS, FACOG, is working to shed light on and address the multifaceted needs of female patients with cancer and survivors, including sexual dysfunction, with the Menopause Urogenital Sexual Health and Intimacy Clinic.

Women with breast cancer whose BMI fell in the overweight or obese ranges achieved meaningful weight loss via a telephone-based intervention, according to phase 3 study results.

Women who have prediabetes before transition to menopause have a higher risk for sustaining a fracture later in life than women without prediabetes, according to a study published in JAMA Network Open.

BALTIMORE — Treatment with once-daily oral fezolinetant was effective for reducing moderate to severe hot flashes associated with menopause in a diverse population, according to findings reported at the ACOG Annual Clinical & Scientific Meeting.

BALTIMORE — Today, the president of the American Congress of Obstetricians and Gynecologists spoke to attendees of the 2023 annual meeting regarding the importance of mental health and overcoming women’s health challenges in the past year.

The ACOG Annual Clinical & Scientific Meeting will have a heavy focus on overcoming current challenges, including diversity, equity and inclusion, in women’s health.

During the transition to menopause many women may experience adverse changes to multiple cardiovascular risk factors, according to a North American Menopause Society Practice Pearl published in Menopause.

The Healio Editors compiled news on menopause in women’s health for National Women’s Health Week.